Cardiac magnetic resonance in transfusion dependent thalassaemia: Assessment of iron load and relationship to left ventricular ejection fraction

British Journal of Haematology

Volumn 151, Issue 4, 2010, Pages 397-401

  Chouliaras, Giorgos L ^a   Kattamis, Antonis ^a   Berdoukas, Vasilis ^a   Gotsis, Efstathios D ^b   Mavrogeni, Sophie ^c   Ladis, Vassilis ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b Encephalos MRI Unit   (Greece)

^c ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Cardiac magnetic resonance imaging (CMR); Left ventricular ejection fraction (LVEF); Thalassaemia; Transfusion iron overload

Indexed keywords

ADULT; ARTICLE; BLOOD TRANSFUSION; CARDIOTOXICITY; DIAGNOSTIC VALUE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; RADIOCARDIOGRAPHY; RISK FACTOR; THALASSEMIA MAJOR;

ADULT; BETA-THALASSEMIA; BLOOD TRANSFUSION; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; IRON OVERLOAD; MAGNETIC RESONANCE IMAGING; MALE; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; YOUNG ADULT;

EID: 77958543057     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08365.x     Document Type: Article

References (11)

1. Anderson, L.J., Holden, S., Davis, B., Prescott, E., Charrier, C.C., Bunce, N.H., Firmin, D.N., Wonke, B., Porter, J., Walker, J.M. & Pennell, D.J. (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. European Heart Journal, 22, 2171-2179.
2. Berdoukas, V., Chouliaras, G., Moraitis, P., Zannikos, K., Berdoussi, E. & Ladis, V. (2009) The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study. Journal of Cardiovascular Magnetic Resonance, 11, 20.doi:.
3. Borgna-Pignatti, C., Rugolotto, S., De Stefano, P., Zhao, H., Cappellini, M.D., Del Vecchio, G.C., Romeo, M.A., Forni, G.L., Gamberini, M.R., Ghilardi, R., Piga, A. & Cnaan, A. (2004) Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica, 89, 1187-1193.
4. Economou-Petersen, E., Aessopos, A., Kladi, A., Flevari, P., Karabatsos, F., Fragodimitri, C., Nicolaidis, P., Vrettou, H., Vassilopoulos, D., Karagiorga-Lagana, M., Kremastinos, D.T. & Petersen, M.B. (1998) Apolipoprotein E epsilon4 allele as a genetic risk factor for left ventricular failure in homozygous beta-thalassemia. Blood, 92, 3455-3459.
5. Esposito, B.P., Breuer, W., Sirankapracha, P., Pootrakul, P., Hershko, C. & Cabantchik, Z.I. (2003) Labile plasma iron in iron overload: redox activity and susceptibility to chelation. Blood, 102, 2670-2677.
6. Ferrara, M., Matarese, S.M., Francese, M., Borrelli, B., Coppola, L., Coppola, A., Iarussi, D. & Esposito, L. (2001) Role of apolipoprotein E (APOE) polymorphism on left cardiac failure in homozygous beta thalassaemic patients. British Journal of Haematology, 114, 959-960.
7. Kirk, P., Roughton, M., Porter, J.B., Walker, J.M., Tanner, M.A., Patel, J., Wu, D., Taylor, J., Westwood, M.A., Anderson, L.J. & Pennell, D.J. (2009) Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation, 120, 1961-1968.
8. Ladis, V., Chouliaras, G., Berdousi, H., Kanavakis, E. & Kattamis, C. (2005) Longitudinal study of survival and causes of death in patients with thalassemia major in Greece. Annals of the New York Academy of Sciences, 1054, 445-450.
9. Maggio, A., Vitrano, A., Capra, M., Cuccia, L., Gagliardotto, F., Filosa, A., Magnano, C., Rizzo, M., Caruso, V., Gerardi, C., Argento, C., Campisi, S., Cantella, F., Commendatore, F., D'Ascola, D.G., Fidone, C., Ciancio, A., Galati, M.C., Giuffrida, G., Cingari, R., Giugno, G., Lombardo, T., Prossomariti, L., Malizia, R., Meo, A., Roccamo, G., Romeo, M.A., Violi, P., Cianciulli, P. & Rigano, P. (2009) Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial Under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies. Blood Cells Molecules and Diseases, 42, 247-251.
10. Patton, N., Brown, G., Leung, M., Bavishi, K., Taylor, J., Lloyd, J., Lee, S.H., Tay, L. & Worthley, S. (2010) Observational study of iron overload as assessed by magnetic resonance imaging (MRI) in an adult population of transfusion dependent patients with beta thalassaemia: significant association between low cardiac T2* < 10 ms and the occurrence of cardiac events. Internal Medicine Journal, 40, 419-426.
11. Westwood, M.A., Anderson, L.J., Maceira, A.M., Shah, F.T., Prescott, E., Porter, J.B., Wonke, B., Walker, J.M. & Pennell, D.J. (2007) Normalized left ventricular volumes and function in thalassemia major patients with normal myocardial iron. Journal of Magnetic Resonance Imaging, 25, 1147-1151.